Gainers
- SINTX Techs SINT shares increased by 75.0% to $0.41 during Tuesday's after-market session. The market value of their outstanding shares is at $2.1 million.
- NuCana NCNA stock rose 10.0% to $0.33. The market value of their outstanding shares is at $17.4 million.
- CNS Pharma CNSP stock rose 7.39% to $0.25. The company's market cap stands at $1.5 million.
- OneMedNet ONMD stock moved upwards by 6.66% to $1.6. The company's market cap stands at $51.6 million.
- Galecto GLTO stock moved upwards by 5.04% to $0.67. The market value of their outstanding shares is at $18.1 million.
- Accelerate Diagnostics AXDX shares moved upwards by 5.0% to $1.47. The company's market cap stands at $29.7 million.
Losers
- Solid Biosciences SLDB shares decreased by 10.3% to $7.25 during Tuesday's after-market session. The market value of their outstanding shares is at $269.3 million.
- Spruce Biosciences SPRB stock fell 10.22% to $3.08. The market value of their outstanding shares is at $125.3 million.
- Celularity CELU shares fell 7.88% to $0.31. The market value of their outstanding shares is at $67.1 million.
- Assure Hldgs IONM stock declined by 7.45% to $0.23. The company's market cap stands at $1.5 million.
- Petros Pharma PTPI stock decreased by 6.51% to $1.15. The company's market cap stands at $2.5 million.
- Iterum Therapeutics ITRM shares fell 5.7% to $1.49. The market value of their outstanding shares is at $20.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CELUCelularity Inc
$2.334.72%
CNSPCNS Pharmaceuticals Inc
$0.11131.18%
GLTOGalecto Inc
$4.812.78%
IONMAssure Holdings Corp
$1.863539.9%
ITRMIterum Therapeutics PLC
$1.771.15%
NCNANuCana PLC
$1.21-%
ONMDOneMedNet Corp
$1.4336.2%
PTPIPetros Pharmaceuticals Inc
$0.2700-13.5%
SINTSINTX Technologies Inc
$3.47-5.19%
SLDBSolid Biosciences Inc
$4.163.74%
SPRBSpruce Biosciences Inc
$0.3731-2.36%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in